Inventor · disambiguated record
Ulf Bömer
Also filed as: BOEMER ULF · BOMER ULF · Bömer Ulf
67 granted patents·39 pending applications·264 citations·filing 2003–2024
98Inventor score
Top patents by PatentIndex Score
106 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0294US9284319B2Heterocyclyl aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Mar 15, 2016·28 cites·5 claims
- 0393US10729680B25-substituted 2-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2017·Granted Aug 4, 2020·10 cites·14 claims
- 0492US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0592US9320737B2Substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted Apr 26, 2016·27 cites·12 claims
- 0690US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0790US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0890US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 0990US9730929B2Substituted aminoimidazopyridazinesEIS KNUT·Filed 2012·Granted Aug 15, 2017·25 cites·14 claims
- 1090US8987273B2Substituted imidazo[1,2-B]pyridazinesREHWINKEL HARTMUT·Filed 2011·Granted Mar 24, 2015·28 cites·18 claims
- 1188US11998539B2Substituted aminoquinolones as DGKalpha inhibitors for immune activationBAYER AG·Filed 2022·Granted Jun 4, 2024·1 cites·24 claims
- 1285US10435396B22-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugsBayer Pharma AG·Filed 2017·Granted Oct 8, 2019·7 cites·8 claims
- 1383US8916557B2Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-aminesLücking Ulrich·Filed 2012·Granted Dec 23, 2014·4 cites·15 claims
- 1483US8148411B22-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticalsBOTHE ULRICH·Filed 2008·Granted Apr 3, 2012·9 cites·6 claims
- 1581US9340528B2Substituted aminoquinoxalines as tyrosine threonine kinase inhibitorsBADER BENJAMIN·Filed 2010·Granted May 17, 2016·12 cites·6 claims
- 1680US9670202B2Substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Jun 6, 2017·2 cites·16 claims
- 1780US9206184B2Disubstituted benzothienyl-pyrrolotriazines and uses thereofBAYER IP GMBH·Filed 2012·Granted Dec 8, 2015·4 cites·4 claims
- 1879US9133171B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Sep 15, 2015·5 cites·13 claims
- 1978US7504410B2Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Mar 17, 2009·13 cites·22 claims
- 2075US9669034B24-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine groupLücking Ulrich·Filed 2012·Granted Jun 6, 2017·2 cites·12 claims
- 2175US9409889B2Amino-substituted imidazopyridazinesBayer Pharma AG·Filed 2013·Granted Aug 9, 2016·3 cites·9 claims
- 2275US9278925B2Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-oneLIU NINGSHU·Filed 2012·Granted Mar 8, 2016·3 cites·8 claims
- 2374US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 2474US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 2574US9499547B2Amino-substituted imidazopyridazinesEIS KNUT·Filed 2012·Granted Nov 22, 2016·3 cites·16 claims
- 2673US9963464B2Macrocyclic compoundsBayer Pharma AG·Filed 2015·Granted May 8, 2018·2 cites·29 claims
- 2773US9877954B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2017·Granted Jan 30, 2018·1 cites·15 claims
- 2873US9000026B2Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapyLIU NINGSHU·Filed 2012·Granted Apr 7, 2015·2 cites·7 claims
- 2973US8975265B2Substituted imidazo[1,2-a]pyrimidines and —pyridinesINCE STUART·Filed 2011·Granted Mar 10, 2015·3 cites·10 claims
- 3073US7897626B22-substituted thiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticalsBAYER SCHERING PHARMA AG·Filed 2008·Granted Mar 1, 2011·2 cites·10 claims
- 3172US9540392B2ThienopyrimidinesBayer Pharma AG·Filed 2013·Granted Jan 10, 2017·2 cites·10 claims
- 3272US9370517B2Substituted pyrazolopyrimidines as Akt kinase inhibitorsBAYER IP GMBH·Filed 2013·Granted Jun 21, 2016·2 cites·8 claims
- 3372US8163739B22-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticalsBOTHE ULRICH·Filed 2008·Granted Apr 24, 2012·2 cites·2 claims
- 3472US2022153745A1Disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitorsBAYER IP GMBH·Filed 2021·Application pending·0 cites
- 3571US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 3670US9650340B25-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted May 16, 2017·1 cites·9 claims
- 3770US8895549B2Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisSCOTT WILLIAM JOHNSTON·Filed 2011·Granted Nov 25, 2014·2 cites·15 claims
- 3870US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 3969US9499492B24-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine groupBayer Pharma AG·Filed 2013·Granted Nov 22, 2016·1 cites·14 claims
- 4069US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 4167US9206185B2Imidazopyridazines as Akt kinase inhibitorsBärfacker Lars·Filed 2012·Granted Dec 8, 2015·2 cites·39 claims
- 4267US9108926B2Disubstituted 5-fluoro-pyrimidinesLücking Ulrich·Filed 2012·Granted Aug 18, 2015·1 cites·11 claims
- 4367US8957064B2Fused pyrimidinesVENNEMANN MATTHIAS·Filed 2010·Granted Feb 17, 2015·3 cites·13 claims
- 4467US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 4566US9790189B2Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine groupBayer Pharma AG·Filed 2015·Granted Oct 17, 2017·1 cites·26 claims
- 4661US8729082B2Substituted imidazoquinoxalinesKOPPITZ MARCUS·Filed 2010·Granted May 20, 2014·1 cites·13 claims
- 4761US2025066370A1Bicyclic triazine derivatives for the treatment of cancerDEUTSCHES KREBSFORSCH·Filed 2023·Application pending·0 cites
- 4860US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 4957US12478621B2Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Granted Nov 25, 2025·0 cites·17 claims
- 5057US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
Showing the top 50 of 106 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →